Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Dec 13;22(1):915.
doi: 10.1186/s13063-021-05802-8.

Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls

S Yogeshkumar  1 , Jean Anderson  2 , Enriquito Lu  3 , Edward Kenyi  4 , Margaret Mensa  3 , Katrina Thaler  2 , Ramalingappa Antartani  5 , Kasturi Donimath  5 , Basavaraj Patil  6 , Santosh Chikaraddi  6 , Shailaja Bidri  7 , Aruna Biradar  7 , Muttappa R Gudadinni  7 , Laxmikant Lokare  5 , Gayane Yenokyan  8 , Mrutyunjaya B Bellad  1 , Shivaprasad S Goudar  1 , Richard Derman  9 , Amit Revankar  1 , Hema Patil  1 , Ramadevi Wani  1 , Ranjit Kangle  1 , Ramesh Y Chavan  1 , Mahantesh B Nagmoti  1 , Yogendra M Kabadi  5 , Purushotham Reddy  5 , Sunita Vernekar  5 , Surekha Hipparagi  7 , Vijayalaxmi Patil  7 , Anita Dalal  1
Affiliations
Multicenter Study

Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls

S Yogeshkumar et al. Trials. .

Abstract

Background: Cervical cancer is the fourth most common cancer in the world, affecting mainly women residing in low- and middle-income countries. Progression from a pre-invasive phase to that of an invasive phase generally takes years and provides a window of opportunity to screen for and treat precancerous lesions.

Methods: This study is being conducted at four sites in north Karnataka, India. Community sensitization activities have been organized in the study areas to create awareness among stakeholders, including elected representatives, physicians, health care workers, and potential participants. Organized community based as well as hospital-based screening is being conducted using visual inspection with acetic acid (VIA). Screen positive women are referred to respective study hospitals for colposcopy and directed biopsy. Participants with confirmed high-grade cervical dysplasia (high-grade squamous intraepithelial lesions or HSIL) who fit all other eligibility criteria will be recruited to the study and will receive cryotherapy using CryoPop®, an innovative new cryotherapy device.

Discussion: There is a need to develop an inexpensive, simple, and effective cryotherapy device for use by frontline health care providers at locations where screening and timely treatment can be given, accelerating access to cervical cancer prevention services and minimizing loss to follow-up of women with precancerous lesions who need treatment.

Trial registration: Clinical Trial Registry - India CTRI/2019/01/017289 ClinicalTrials.Gov number NCT04154644 . Registered on November 6, 2019.

Keywords: Cervical dysplasia; CryoPop®; Cryotherapy; Low- and middle-income countries.

PubMed Disclaimer

Conflict of interest statement

The authors declared no conflict of interests.

Figures

Fig. 1
Fig. 1
CryoPop® Device (Pregna. Accessed 15 April 2021 https://tinyurl.com/yzrpqwrh)
Fig. 2
Fig. 2
CryoPop® study schedule of enrollment, intervention, and assessments
Fig. 3
Fig. 3
CryoPop® study schedule of case report forms by visits
See this image and copyright information in PMC

References

    1. Arbyn M, Weiderpass E, Bruni L, San Jose S, Saraiya M, Ferlay J. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. doi: 10.1016/S2214-109X(19)30482-6. - DOI - PMC - PubMed
    1. Moving cancer up the global health agenda. Lancet. 2010;375(9371):2051. 10.1016/S0140-6736(10)60942-7. - PubMed
    1. Sawaya G, Grimes D. New technologies in cervical cytology screening: a word of caution. Obstet and Gynecol. 1999;94(2):307–310. - PubMed
    1. Van der Graaf Y, Klinkhamer PJJM, Vooijs GP. Effect of population screening for cancer of the uterine cervix in Nijmegen, The Netherlands. Prev Med. 1986;15(6):582–590. doi: 10.1016/0091-7435(86)90063-0. - DOI - PubMed
    1. Eddy DM. Screening for cervical cancer. Ann Intern Med. 1990;113(3):214–226. doi: 10.7326/0003-4819-113-3-214. - DOI - PubMed

Associated data